Breaking News, Collaborations & Alliances

Samsung Biologics Joins the Pharmaceutical Supply Chain Initiative

Will embed PSCI principles into its business practices for responsible value chain management.

Author Image

By: Charlie Sternberg

Associate Editor

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner—making it the first Korean CDMO to participate in the PSCI, a group of pharmaceutical and healthcare companies that share a common vision of excellence in safety, environmental, and social outcomes across the global healthcare value chain.   Samsung Biologics will commit to PSCI principles that address five areas of responsib...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters